Profile data is unavailable for this security.
About the company
Profound Medical Corp. is a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), AI-enhanced planning, robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low-, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (BPH); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. It is also commercializing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.
- Revenue in CAD (TTM)19.47m
- Net income in CAD-53.57m
- Incorporated2014
- Employees131.00
- LocationProfound Medical Corp2400 Skymark Ave Unit 6MISSISSAUGA L4W 5K5CanadaCAN
- Phone+1 (647) 476-1350
- Fax+1 (647) 476-1350
- Websitehttps://profoundmedical.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Theralase Technologies Inc | 1.00m | -4.35m | 77.12m | 0.00 | -- | 70.57 | -- | 77.04 | -0.0174 | -0.0174 | 0.004 | 0.0043 | 0.3215 | 0.8203 | 1.39 | -- | -139.83 | -73.48 | -244.27 | -85.81 | 55.34 | 46.93 | -434.88 | -486.10 | 0.5668 | -- | 0.2264 | -- | -3.45 | 1.40 | 6.89 | -- | -48.16 | -- |
| Hydreight Technologies Inc | 24.48m | 453.24k | 195.09m | -- | 382.32 | 18.24 | 232.01 | 7.97 | 0.0096 | 0.0096 | 0.5532 | 0.2004 | 1.95 | -- | 99.69 | -- | 3.62 | -- | 5.38 | -- | 29.16 | -- | 1.85 | -- | -- | -- | 0.4544 | -- | 39.40 | -- | 79.09 | -- | -- | -- |
| Healwell Al Inc | 100.17m | -47.21m | 197.06m | 350.00 | -- | 1.72 | -- | 1.97 | -0.351 | -0.4015 | 0.5373 | 0.3891 | 0.4576 | -- | 4.42 | 286,205.70 | -21.85 | -36.75 | -31.35 | -56.76 | 50.39 | 35.09 | -47.75 | -65.92 | -- | -6.77 | 0.4162 | -- | 432.62 | -3.38 | 18.49 | -- | 60.84 | -- |
| Profound Medical Corp | 19.47m | -53.57m | 323.25m | 131.00 | -- | 6.14 | -- | 16.60 | -1.82 | -1.82 | 0.6715 | 1.45 | 0.3396 | 0.5325 | 2.06 | -- | -93.45 | -39.19 | -116.44 | -42.46 | 72.49 | 53.69 | -275.18 | -354.00 | 3.34 | -- | 0.1289 | -- | 48.35 | 20.67 | 1.79 | -- | -- | -- |
| Richards Group Inc | 424.12m | 22.37m | 324.65m | 544.00 | 14.32 | 1.59 | 8.13 | 0.7655 | 1.99 | 1.99 | 37.91 | 17.99 | 1.15 | 3.90 | 7.82 | 779,626.80 | 6.08 | 10.32 | 8.21 | 15.13 | 18.49 | 19.79 | 5.27 | 7.75 | 0.6465 | 6.83 | 0.3306 | 51.48 | -4.26 | 4.06 | -7.84 | 10.52 | -8.67 | 0.00 |
| Vitalhub Corp | 98.17m | 2.83m | 505.22m | 500.00 | 156.02 | 1.93 | 40.68 | 5.15 | 0.0512 | 0.0512 | 1.72 | 4.15 | 0.3581 | 49.42 | 8.00 | 196,334.70 | 1.03 | 0.974 | 1.32 | 1.25 | 80.92 | 80.67 | 2.88 | 2.33 | 1.94 | -- | 0.0061 | 0.00 | 30.64 | 46.32 | -34.08 | -- | 62.14 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Gagnon Securities LLCas of 04 Apr 2025 | 3.35m | 9.22% |
| Fidelity Investments Canada ULCas of 30 Sep 2025 | 1.89m | 5.19% |
| Letko, Brosseau & Associates, Inc.as of 30 Sep 2024 | 1.20m | 3.30% |
| Rosalind Advisors, Inc.as of 31 Dec 2025 | 1.07m | 2.95% |
| Royce & Associates LPas of 31 Dec 2025 | 990.35k | 2.73% |
| Timelo Investment Management, Inc.as of 31 Dec 2025 | 979.97k | 2.70% |
| Gagnon Advisors LLCas of 31 Dec 2024 | 896.67k | 2.47% |
| Alyeska Investment Group LPas of 31 Dec 2025 | 678.57k | 1.87% |
| MM Asset Management, Inc.as of 31 Dec 2025 | 531.36k | 1.46% |
| Ring Mountain Capital LLCas of 31 Dec 2025 | 454.08k | 1.25% |
